Prediction of model for complete cytogenetic response
. | . | . | . | Estimated 4-y rate, % . | . | |
|---|---|---|---|---|---|---|
. | No. of adverse factors* . | No. of patients . | No. of patients with complete cytogenetic response (%) . | Progression-free . | Survival . | |
| Risk group | ||||||
| Good | 0 | 65 | 61 (94) | 94 | 94 | |
| Intermediate | 1 | 132 | 77 (58) | 81 | 88 | |
| Poor | 2 | 57 | 22 (39) | 59 | 73 | |
| P | .0001 | < .0001 | .007 | |||
. | . | . | . | Estimated 4-y rate, % . | . | |
|---|---|---|---|---|---|---|
. | No. of adverse factors* . | No. of patients . | No. of patients with complete cytogenetic response (%) . | Progression-free . | Survival . | |
| Risk group | ||||||
| Good | 0 | 65 | 61 (94) | 94 | 94 | |
| Intermediate | 1 | 132 | 77 (58) | 81 | 88 | |
| Poor | 2 | 57 | 22 (39) | 59 | 73 | |
| P | .0001 | < .0001 | .007 | |||
Adverse factors: Ph positivity at start more than 90%, platelets more than 450 × 109/L.